SCHEMBL5156747

SCHEMBL5156747

COc1ccccc1C(=O)NCCc1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.74
HPGD P15428 2/20 0.73
TP53 P04637 1/20 0.73
GLA P06280 1/20 0.73
NPC1 O15118 4/20 0.68
RAB9A P51151 4/20 0.68
MAPT P10636 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.66
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
GBA1 P04062 1/20 0.62
GAA P10253 1/20 0.62
ALDH1A1 P00352 1/20 0.60
CTSD P07339 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5750464 0.91 TAAR1 (0.62) TAAR1HPGDTP53GLANPC1
SCHEMBL11356684 0.90 TAAR1 (0.61) TAAR1HPGDTP53GLANPC1
SCHEMBL17554092 0.90 TAAR1 (0.64) TAAR1HPGDTP53GLANPC1
SCHEMBL5188499 0.89 TAAR1 (0.59) TAAR1HPGDTP53GLANPC1
SCHEMBL11684013 0.86 DNMT3A (0.65) TAAR1HPGDTP53GLANPC1
SCHEMBL6267575 0.86 CYP1A2 (0.65) HPGDTP53NPC1RAB9AMAPT
SCHEMBL167922 0.85 NPC1 (0.63) TAAR1HPGDTP53GLANPC1
SCHEMBL27604453 0.84 HPGD (1.00) HPGDTP53GLARAB9AMAPT
SCHEMBL28568182 0.84 ALDH1A1 (0.79) KMT2AGAAALDH1A1
SCHEMBL29385160 0.84 ALDH1A1 (0.79) KMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1126836-B1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2007-02-14 EP disclosed
CN-1520298-A Pyrazolopyrimidines as therapeutic agents �����ʩ���عɷݹ�˾ 2004-08-11 CN disclosed
US-6194458-B1 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS MERCK & CO., INC. 2001-02-27 US disclosed